VOTUBIA cpr disp 3 mg 30 pce

7680628120026 CH-62812 L01XE10 07.16.4.

Reimbursement limitations:

VOTUBIA4

Chez les patients atteints de sclérose tubéreuse:
- pour le traitement d’astrocytomes sous-épendymaires à cellules …

VOTUBIA cpr disp 3 mg 30 pce
VOTUBIA cpr disp 3 mg 30 pce
VOTUBIA cpr disp 3 mg 30 pce
1 / 3
google

Details

Product number
6281202
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
everolimusum 3 mg, lactosum monohydricum 2.94 mg, hypromellosum, mannitolum, cellulosum microcristallinum, crospovidonum, magnesii stearas, silica colloidalis anhydrica, E 321 pro compresso.

Articles (1)

Votubia 3 mg, dispergierbare Tabletten
Tabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
2.94 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX

Reimbursement information

Public price
CHF 1502.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2014

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
62812
Drug name
Votubia, dispergierbare Tabletten
Galenic form
TAB
ATC Code
L01XE10
Authorization status
Z
Dispensation category
A
First authorization
17/01/2014
Authorization expiration date
31/12/9999
IT number
07.16.4.
Domain
Human medicine
Field of application
Tuberöse Sklerose

Packaging details

Description (FR)
VOTUBIA cpr disp 3 mg 30 pce
Description (DE)
VOTUBIA Disp Tabl 3 mg 30 Stk
Market launch
17/01/2014
Narcotic (BTM)
No

Other packaging sizes

VOTUBIA cpr disp 2 mg 30 pce
30 TABL
View